Skip to main content

Volume 17 - Issue 8 - August, 2005

Case Report
08/01/2008
Elaine P. Wang, MD; Wai-Hong Chen, MBBS; Pui-Yin Lee, MBBS
Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI). The incidence is 0.1% with lesions treated by balloon angioplasty and 0.5–3.0% with lesions treated by atheroablative devices.1 It can...
Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI). The incidence is 0.1% with lesions treated by balloon angioplasty and 0.5–3.0% with lesions treated by atheroablative devices.1 It can...
Coronary artery perforation is a...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Enio E. Guarios, MD, PhD; Ronaldo R.L. Bueno, MD, PhD; Deborah Nercolini, MD; José C. Tarastchuk, MD; Paulo M. Andrade, MD; Alvaro Pacheco, MD; Alysson Faidiga, MD; Stefan Negrao, MD; Antonio Barbosa, MD
Several studies have determined the safety and efficacy of percutaneous mitral valvuloplasty (PMV) during pregnancy, the larger series being those recently described by Esteves,122 Nercolini et al.,118 and Ben Farhat et al.120 Retrospectively...
Several studies have determined the safety and efficacy of percutaneous mitral valvuloplasty (PMV) during pregnancy, the larger series being those recently described by Esteves,122 Nercolini et al.,118 and Ben Farhat et al.120 Retrospectively...
Several studies have determined...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Renato DeRita, MS; Barry S. George, MD, FACC, FSCAI; Fayaz Shawl, MD; Christopher U. Cates, MD; Michael R. Mooney, MD; Jiri J. Vitek, MD, PhD; Norberto Schechtmann, MD
Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...
Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...
Barry George: Needless to say,...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology contains numerous original clinical research studies and related commentaries. We start the issue with a submission from Dr. Marco Costa and colleagues representing investigators...
Dear Readers, This issue of the Journal of Invasive Cardiology contains numerous original clinical research studies and related commentaries. We start the issue with a submission from Dr. Marco Costa and colleagues representing investigators...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Marco A. Costa, MD, PhD; Andrew J. Carter, DO, FACC; Paul S. Teirstein, MD, FACC; Martin B. Leon, MD; Martin Zenni, MD; Theodore A. Bass, MD; Steven J. Yakubov, MD; Paul Gilmore, MD; Jeffrey W. Moses, MD; Tim A. Fischell, MD, FACC, FSCAI; Dominick J. Angiolillo, MD, PhD
Treatment options for bypass graft disease, such as repeat CABG and percutaneous revascularization, are limited and provide disappointing outcomes.1-4 Patients undergoing repeat CABG have over a four times greater rate of mortality compared...
Treatment options for bypass graft disease, such as repeat CABG and percutaneous revascularization, are limited and provide disappointing outcomes.1-4 Patients undergoing repeat CABG have over a four times greater rate of mortality compared...
Treatment options for bypass...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
James B. Hermiller, MD, FACC, MSCAI
Despite the promise of new transcatheter technologies, 400,000 coronary artery bypass (CABG) surgeries are performed each year in the United States, the vast majority incorporating saphenous vein grafts (SVG) as conduits.1 Soon after...
Despite the promise of new transcatheter technologies, 400,000 coronary artery bypass (CABG) surgeries are performed each year in the United States, the vast majority incorporating saphenous vein grafts (SVG) as conduits.1 Soon after...
Despite the promise of new...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Vassilis Voudris, MD; Athanassios Manginas, MD; Dennis V. Cokkinos, MD; Elias Alexopoulos, MD; Konstantinos Spargias, MD, PhD; Panagiotis Karyofillis, MD; John Malakos, MD; Gregory Pavlides, MD; Sotirios Patsilinakos, MD, PhD; Alexandros Anyfantakis, MD
Percutaneous coronary intervention is an established method of nonsurgical coronary revascularization, accounting for more than 1,500,000 annual procedures worldwide.1 Despite technical advancements in recent years, with coronary stenting...
Percutaneous coronary intervention is an established method of nonsurgical coronary revascularization, accounting for more than 1,500,000 annual procedures worldwide.1 Despite technical advancements in recent years, with coronary stenting...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Hannah M. Timlin, BSc; Sarah A. Carnaffin, RGN; Ian R. Starkey, MB, FRCP; David B. Northridge, MB, FRCP; Stephen J. Leslie, BSc, MB, MRCP, PhD
Percutaneous coronary intervention (PCI) is central to the management of patients with coronary artery disease. Vascular access is most commonly achieved via the femoral artery by inserting a vascular access sheath. To reduce the risk of...
Percutaneous coronary intervention (PCI) is central to the management of patients with coronary artery disease. Vascular access is most commonly achieved via the femoral artery by inserting a vascular access sheath. To reduce the risk of...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Pim J. de Feyter, MD, PhD; Ron T. van Domburg, PhD; Hector M. Garcia-Garcia, MD, PhD; Andrew T.L. Ong, MD, MBBS, PhD; Carlos A.G. van Mieghem, MD; Keiichi Tsuchida, MD; Gaston A. Alfredo Rodriguez-Granillo, MD; Jiro Aoki, MD; Marco Valgimigli, MD, PhD, FESC; Patrick W. Serruys, MD, PhD; Eugene P. McFadden, MB, MD; Georgios Sianos, MD, PhD; Willem J. van der Giessen, MD, PhD
Coronary stenting has significantly improved the angiographic and clinical outcomes in vessels with a reference diameter (RD) > 3 mm.1–5 However, several randomized trials have shown conflicting results when comparing coronary stenting...
Coronary stenting has significantly improved the angiographic and clinical outcomes in vessels with a reference diameter (RD) > 3 mm.1–5 However, several randomized trials have shown conflicting results when comparing coronary stenting...
Coronary stenting has...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Ariel Roguin, MD, PhD; Ehud Grenadier, MD
Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...
Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...
Stent placement in coronary...
08/01/2008
Journal of Invasive Cardiology